The printer specialist has been fighting a battle since 2007 to get cartridges that are manufactured in China but sold by Medea in the UK taken off the market and earlier this summer successfully stopped eBuyer from selling the Inkrite range.
A court date was looming for Medea but the company has decided not to fight and question the validity of Epson's patents by withdrawing brands including Inkrite, JR Inkjet and Inkjet from sale. Medea is also paying an undisclosed sum to the vendor to cover costs and damages.
Matthew Drew, group product manager at Epson, said that it was pleased the case had reached this conclusion.
"Attempts to copy our technologies impact both on us as a brand and on our customers' experiences. We will continue to take a proactive stance to protect our brand, our channel partners and our customers.," he said.